BENITEC BIOPHARMA INC (BNTC)
US08205P2092 - Common Stock
| TTM (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | -18.06M | -18.01M | -15.90M | -12.83M | -7.54M | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| OPERATING CASH FLOW | -18.06M | -18.01M | -15.90M | -12.83M | -7.54M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -10.00K | -220.00K | -100.00K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | N/A | 0.00 | -10.00K | -220.00K | -90.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 30.92M | 17.88M | 0.00 | 25.75M | 2.25M | |||
| Other Financing Activity | -2.96M | -1.87M | 0.00 | -3.23M | -480.00K | |||
| FINANCING CASH FLOW | 27.96M | 16.02M | 0.00 | 22.52M | 1.77M | |||
| Exchange Rate Effect | -58.00K | 410.00K | 200.00K | 500.00K | -60.00K | |||
| CHANGE IN CASH | 9.84M | -1.58M | -15.71M | 9.97M | -5.92M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.06M | -18.01M | -15.90M | -12.83M | -7.54M | |||
| Capital Expenditure | N/A | 0.00 | -10.00K | -220.00K | -100.00K | |||
| FREE CASH FLOW | -18.06M | -18.01M | -15.91M | -13.05M | -7.64M | |||
All data in USD